Primary CNS Lymphoma (PCNSL) research hub

Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab

This study is testing a new drug, epcoritamab, for people in the UK with a type of brain lymphoma called PCNSL that has come back or not responded to previous treatments. It aims to see if adding epcoritamab to an existing treatment improves outcomes for patients.